• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data regarding how exposure over time may affect a foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental conditions like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Pregnant women who take inattentive adhd medication adults medications must weigh the benefits of taking them against potential risks to the fetus. Physicians don't have the necessary data to make unequivocal recommendations however they can provide information about the risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications during early pregnancy did not have an higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large population-based study of case-control to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy, and those who did not. Clinical geneticists and pediatric cardiologists looked over the cases to ensure correct classification of the cases and to reduce the chance of bias.

The study conducted by the researchers had some limitations. The researchers were unable, in the first place to differentiate the effects of the medication from the disorder. This makes it difficult for researchers to determine if the few associations observed between the exposed groups were due to the use of medication or affected by co-morbidities. In addition the researchers did not examine long-term offspring outcomes.

The study revealed that babies whose mothers had taken ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who didn't take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This was due to central nervous system-related disorders, and the increased risk for admission did not appear to be influenced by which stimulant medications were taken during pregnancy.

Women who took stimulant managing adhd without medication medication during pregnancy were also at an elevated risk of having a caesarean birth or having a baby born with an low Apgar score (less than 7). These increases didn't seem to be influenced by the kind of medication used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during early pregnancy may be offset by the higher benefit to both mother and child from continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where they are able, assist them in developing strategies to improve coping skills that may minimize the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the dilemma of whether to continue or discontinue treatment during pregnancy is one that more and more doctors face. Often, these decisions are taken in the absence of solid and reliable evidence regardless, so doctors must weigh their knowledge about their experiences, the experiences of other doctors, and what research suggests on the subject, along with their own best judgment for each individual patient.

In particular, the issue of possible risks to the baby can be a challenge. The research on this issue is based on observations rather than controlled studies, and the results are conflicting. Furthermore, most studies restrict their analysis to live births, which may underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion: While some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no such relationship and the majority of studies demonstrate a neutral or slightly negative impact. In each case an in-depth analysis of the potential risks and benefits is required.

For many women with ADHD, the decision to discontinue medication is difficult, if not impossible. In a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness and family conflict for patients with ADHD. In addition, a decrease in medication may affect the ability to complete jobs and drive safely which are essential aspects of a normal life for a lot of people with ADHD.

She recommends women who are unsure about whether to continue or stop medication in light of their pregnancy, consider informing family members, friends, and coworkers on the condition, its effects on daily functioning, and on the advantages of continuing the current treatment regimen. Educating them can also make the woman feel more comfortable in her struggle with her decision. It is also worth noting that certain medications are able to be absorbed through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the medication could be transferred to the child.

Birth Defects and Adhd Medication Risk of

As the use and abuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD), increases the concern over the potential effects of these drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Utilizing two huge data sets, researchers were able to look at more than 4.3 million pregnancies and determine whether stimulant medication use increased the risk of birth defects. Researchers discovered that, while the risk overall is low, the first trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The authors of the study did not discover any link between the use of early medications and other congenital anomalies, like facial deformities, or club feet. The results are consistent with previous studies revealing a small but significant increase in the risk of developing cardiac malformations in women who started taking adhd medication weight loss uk medications before the time of pregnancy. The risk grew in the latter half of pregnancy, when many women begin to discontinue their ADHD medication.

Women who took adhd and depression medication medication in the first trimester were more likely to require a caesarean birth and also have a low Apgar after birth and had a baby that required help breathing when they were born. However, the authors of the study were not able to eliminate bias due to selection by limiting the study to women who didn't have any other medical conditions that could have contributed to these findings.

The researchers hope that their research will aid in the clinical decisions of physicians who see pregnant women. The researchers suggest that while discussing the risks and benefits are important, the decision about whether to continue or stop medication should be in light of the severity of each woman's ADHD symptoms and her requirements.

The authors also caution that even though stopping the medication is an option, it is not an option that is recommended due to the high incidence of depression and other mental health issues among women who are pregnant or recently post-partum. Research has also shown that women who stop taking their medication will have a harder time adjusting to a life without them after the baby is born.

Nursing

It can be overwhelming to become a mother. Women suffering from ADHD may face a lot of challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to a new routine. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medicines are absorbed by breast milk in small quantities, so the risk to infant who is breastfeeding is low. However, the amount of exposure to medication by the newborn may differ based on the dosage, frequency it is taken and at what time it is administered. Additionally, different medications enter the baby's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn infant is not well understood.

Some physicians may discontinue stimulant medication during a woman's pregnancy due to the absence of research. This is a complicated decision for the patient, who must weigh the benefits of continuing her medication against the potential dangers to the embryo. Until more information becomes available, doctors may ask pregnant patients whether they have a history of strongest adhd medication or if they intend to take medication in the perinatal period.

A increasing number of studies have proven that women can continue taking their ADHD medication during pregnancy and while breastfeeding. In response, a growing number of patients are opting to continue their medication. They have found, in consultation with their doctors, that the benefits of retaining their current medication outweigh any possible risks.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder and learn about treatment options and strengthen existing coping strategies. This should be a multidisciplinary effort together with obstetricians, GPs and psychiatry. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother as well as the child, and monitoring for signs of deterioration, and the need for adjustments to the medication regimen.